Stock A245620 EONE DIAGNOMICS GENOME CENTER CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Eone Diagnomics Genome Center Co., Ltd.

Equities

A245620

KR7245620000

Pharmaceuticals

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-04-04 pm EDT 		5-day change 1st Jan Change
415 KRW -5.25% Intraday chart for Eone Diagnomics Genome Center Co., Ltd. 0.00% -0.72%
Apr. 16 Eone Diagnomics Genome Center Co., Ltd.(KOSDAQ:A245620) dropped from S&P Global BMI Index CI
Apr. 08 Eone Diagnomics Genome Center Co., Ltd. announced that it has received KRW 20 billion in funding CI

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration

Latest news about Eone Diagnomics Genome Center Co., Ltd.

Eone Diagnomics Genome Center Co., Ltd.(KOSDAQ:A245620) dropped from S&P Global BMI Index CI
Eone Diagnomics Genome Center Co., Ltd. announced that it has received KRW 20 billion in funding CI
Eone Diagnomics Genome Center Co., Ltd. announced that it expects to receive KRW 20 billion in funding CI
Eone Diagnomics Genome Center Co., Ltd. acquired GDxLab, INC. CI
Eone Diagnomics Genome Center to Raise 89.4 Billion Won via Stock Sale MT
Eone Diagnomics Genome Center Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Eone Diagnomics Genome Center Co., Ltd. announced that it has received KRW 6 billion in funding from Shinhan Financial Investment Co., Ltd., Samsung Securities Co., Ltd., Mirae Asset Securities Co., Ltd., KB Securities Co., Ltd. CI
Eone Diagnomics Genome Center Co., Ltd. announced that it expects to receive KRW 6 billion in funding from Shinhan Financial Investment Co., Ltd., Samsung Securities Co., Ltd., Mirae Asset Securities Co., Ltd., KB Securities Co., Ltd. CI
MarketScreener's World Press Review : April 11, 2022 Our Logo
Eone Diagnomics Genome Center Co., Ltd. announced that it has received KRW 10 billion in funding from Korea Investment Hanwha Healthcare Private Equity Fund Co. Ltd CI
Eone Diagnomics Genome Center Co., Ltd. announced that it expects to receive KRW 10 billion in funding from Korea Investment Hanwha Healthcare Private Equity Fund Co. Ltd CI
Eone Diagnomics Genome Center Co., Ltd. announced that it has received KRW 30 billion in funding CI
Eone Diagnomics Genome Center Co., Ltd. announced that it expects to receive KRW 30 billion in funding CI
Eone Diagnomics Genome Center Co., Ltd. acquired Natural Life Nutrition Inc. CI
Maple Holdings Co., Ltd. announced that it has received KRW 25 billion in funding from Eone Diagnomics Genome Center Co., Ltd. CI
Eone Diagnomics Genome Center Co.Ltd. agreed to acquire remaining 51.07% stake in EDGC Healthcare Co., Ltd for approximately KRW 140 billion. CI
Eone Diagnomics Genome Center : South Korean test kit makers swamped as coronavirus cases explode in U.S., Europe RE
Eone Diagnomics Genome Center Co.Ltd. announced that it has received KRW 20 billion in funding from Mirae Asset Daewoo Co., Ltd., AJU IB INVESTMENT Co., Ltd., Korea Investment & Securities Co., Ltd., Investment Arm, NH Investment & Securities Co., Ltd. CI
Eone Diagnomics Genome Center Co.Ltd. to Raise USD 17.2 Million in Private Placement of Bonds CI
Eone Diagnomics Genome Center Co.Ltd. announced that it expects to receive KRW 20 billion in funding from Mirae Asset Daewoo Co., Ltd., AJU IB INVESTMENT Co., Ltd., Korea Investment & Securities Co., Ltd., Investment Arm, NH Investment & Securities Co., Ltd., and other investors CI
Eone Diagnomics Genome Center Co.Ltd.(KOSDAQ:A245620) added to S&P Global BMI Index CI
EONE-DIAGNOMICS Genome Center Announces the Release of Liquid Biopsy Screening Service CI
Eone Diagnomics Genome Center Co.Ltd. acquired 49.9% stake in Cns Healthcare, Ltd from Kyungsook Im, Soonbae Cha and Yoonsoon Han. CI
Eone Diagnomics Genome Center Co.Ltd. signed a definitive agreement to acquire 49.9% stake in Cns Healthcare, Ltd from Kyungsook Im, Soonbae Cha and Yoonsoon Han for KRW 19.7 billion. CI
Eone Diagnomics Genome Center Co.Ltd. has completed an IPO in the amount of KRW 46.8 billion. CI

Chart Eone Diagnomics Genome Center Co., Ltd.

Chart Eone Diagnomics Genome Center Co., Ltd.
More charts

Company Profile

Eone Diagnomics Genome Center Co., Ltd. is a Korea-based company engaged in genetic analysis business. The Company is engaged in non-invasive prenatal tests (NIPT), newborn screening tests, ophthalmologist specialist genome analysis tests, customized disease prediction tests, and direct to consumer (DTC) genetic tests, among others. In addition, the Company is developing genome-related software.
Sector
Pharmaceuticals
Calendar
2024-05-12 - Q1 2024 Earnings Release (Projected)
More about the company

Income Statement Evolution

More financial data

Sector Pharmaceuticals Wholesale

1st Jan change Capi.
EONE DIAGNOMICS GENOME CENTER CO., LTD. Stock Eone Diagnomics Genome Center Co., Ltd.
-0.72% 41.7M
MCKESSON CORPORATION Stock McKesson Corporation
+16.27% 71.39B
CARDINAL HEALTH, INC. Stock Cardinal Health, Inc.
+1.72% 25.1B
SINOPHARM GROUP CO. LTD. Stock Sinopharm Group Co. Ltd.
-1.22% 8.59B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD Stock Shanghai Pharmaceuticals Holding Co., Ltd
+7.95% 8.19B
HUADONG MEDICINE CO., LTD Stock Huadong Medicine Co., Ltd
-20.48% 7.91B
JOINTOWN PHARMACEUTICAL GROUP CO., LTD Stock Jointown Pharmaceutical Group Co., Ltd
+15.26% 4.31B
EBOS GROUP LIMITED Stock EBOS Group Limited
-1.24% 3.93B
GALENICA AG Stock Galenica AG
-3.02% 3.86B
CHINA NATIONAL MEDICINES CORPORATION LTD. Stock China National Medicines Corporation Ltd.
+21.10% 3.64B
Pharmaceuticals Wholesale
  1. Stock Market
  2. Equities
  3. A245620 Stock
  4. News Eone Diagnomics Genome Center Co., Ltd.
  5. Eone Diagnomics Genome Center to Raise 89.4 Billion Won via Stock Sale